Pivotal Therapeutics (PVTTF) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free PVTTF Stock Alerts $0.0018 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share HeadlinesStock AnalysisHeadlinesStock AnalysisHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBiden Sees a $35 Price Cap for Insulin as a Pivotal Campaign Issue. It’s Not That Clear-Cutusnews.com - April 21 at 9:55 AMThe Latest | Jury Selection Enters a Pivotal Stretch as Trump's Hush Money Trial Resumesmsn.com - April 18 at 9:12 AMJury Selection in Trump Hush Money Trial Faces Pivotal Stretch as Former President Returns to Courtusnews.com - April 18 at 12:40 AMAnti-Trump Republican Larry Hogan Navigates Dangerous Political Terrain in Pivotal Senate Contestusnews.com - April 17 at 12:38 AMAmen Corner Proves Pivotal as Scottie Scheffler's Closest Pursuers Falter in Final Round of Mastersmsn.com - April 14 at 8:54 PMSpotify target raised to new Street high at Pivotal Researchinvesting.com - April 5 at 2:04 PMProtembis GmbH: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trialfinanznachrichten.de - April 2 at 1:25 AMProtembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trialfinance.yahoo.com - April 2 at 1:25 AMJenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancetfinance.yahoo.com - March 28 at 9:45 AMBuy Rating for Viridian Therapeutics Backed by Strong Financials and Promising Drug Candidatemarkets.businessinsider.com - February 28 at 7:04 PMPivotal, the flying-car company backed by Google cofounder Larry Page, lays off 10% of staffbusinessinsider.com - February 24 at 12:53 AMPivotal Delivers Four BlackFly light eVTOLs for U.S. Air Force evaluation; Contracted for Eight Aircraftmarkets.businessinsider.com - February 22 at 9:40 AMPivotal Commware Promotes FWA Without Limits at 2024 Mobile World Congress Barcelonatmcnet.com - February 22 at 9:40 AMDCC Animal Hospital onboards Dr. Prabhakaran Palanichamy as Senior Veterinary Expertmsn.com - February 9 at 7:34 AMVertex's (VRTX) Q4 Earnings and Sales Surpass Estimatesmsn.com - February 6 at 1:10 PMGlobal Downstream Processing Market to Surpass 83.47 Billion by 2030 Driven by Rising Demand for Biopharmaceuticalsfinance.yahoo.com - February 5 at 3:43 PMVertex non-opioid painkiller shows positive results in critical late-stage trial on acute painmsn.com - January 30 at 6:05 PMViridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended ...businesswire.com - December 18 at 8:27 AMPivotal Life Sciences Announces the Closing of $389M for Pivotal bioVenture Partners Fund IIfinance.yahoo.com - December 18 at 8:27 AMGlobal Semiconductor Industry Outlook 2024finance.yahoo.com - December 12 at 5:45 PMNuclear Medicine Market Valuation to Soar at 11.5% by 2030, Global Revenue to Exceed US$11 Bn: Fairfield Market Researchfinance.yahoo.com - December 12 at 12:43 PMPivotal Appoints Cyrus Sigari to its Board of Directorsmarkets.businessinsider.com - November 21 at 9:43 AMGlobal Neuromuscular Disease Therapeutics Market to Surge by $6.51 Billion by 2027, Driven by Novel Approvals and Screening Testsuk.finance.yahoo.com - October 25 at 7:25 PMJenaValve Trilogy heart valve meets primary endpoints in pivotal trialmsn.com - October 25 at 7:25 PMJenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpointsmarkets.businessinsider.com - October 24 at 8:44 PMProtembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Studyventurebeat.com - October 19 at 1:37 AMVideo Provides First Clear Views of WWII Aircraft Carriers Lost in the Pivotal Battle of Midwayusnews.com - September 30 at 8:35 AMIn the Pivotal South Carolina Primary, Republican Candidates Search for a Path Against Donald Trumpusnews.com - September 4 at 5:06 AMProtagonist Therapeutics: Evaluating Rusfertide's Potential For PVmsn.com - September 4 at 5:06 AMSVB Securities Maintains Viracta Therapeutics (VIRX) Outperform Recommendationmsn.com - August 15 at 11:40 PMViracta Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updatemarkets.businessinsider.com - August 14 at 9:37 AMHow Does Pivotal Response Training (PRT) for Children With Autism Work?msn.com - August 9 at 11:47 AMPivotal Research Sticks to Their Buy Rating for Liberty Broadband (LBRDK)markets.businessinsider.com - August 7 at 7:25 AMSERD Therapeutics Market Recording a Promising CAGR of 17.5% from 2023-2031 | Reveals InsightAce Stuydfinance.yahoo.com - July 25 at 12:48 PMAutolus Therapeutics Presents Positive Results from Pivotal Phase 2 FELIX study in adult r/r B-ALL at ASCOfinance.yahoo.com - June 2 at 9:37 AMTravere Therapeutics Announces Positive Topline Results from Cohort 6 in the Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuriatechnews.tmcnet.com - May 31 at 7:24 AMAutolus Therapeutics to hold Analyst call to highlight data at ASCO from the Pivotal Phase 2 FELIX study of obe-cel data in adult r/r B-ALLbenzinga.com - May 22 at 9:39 AMInsiders Rewarded With AU$135k Addition To Investment As Pivotal Metals Stock Hits AU$17mhk.finance.yahoo.com - May 9 at 11:34 PMPivotal Research Remains a Buy on Dish Network (DISH)markets.businessinsider.com - May 9 at 6:33 PMPivotal Research Maintains Dish Network Corp - (DISH) Buy Recommendationmsn.com - May 9 at 6:33 PMe-therapeutics hails "pivotal year" but sees its losses widenmsn.com - May 5 at 1:54 PMPivotal Research Maintains Hold Rating for Altice USA: Here's What You Need To Knowmarkets.businessinsider.com - May 5 at 1:54 PMPivotal Therapeutics Inc. (PVTTF)finance.yahoo.com - April 23 at 5:55 PMCentury Park Portfolio Company, Pivotal Drive, Merges with Nova CPMbenzinga.com - April 19 at 11:55 PMPivotal Commware Lights Up mmWave Fixed Wireless Coverage in Atlantatmcnet.com - April 19 at 1:55 PMScottsdale-based Pivotal Group acquires Atlanta webcast companybizjournals.com - April 13 at 9:23 AMVivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Studybenzinga.com - March 13 at 10:32 AMPivotal Investment Corp. III to Appeal Delisting Determination by NYSEfinance.yahoo.com - March 1 at 9:27 AMNYSE to Suspend Trading Immediately in Pivotal Investment Corporation III (PICC) and Commence Delisting Proceedingsfinance.yahoo.com - March 1 at 4:24 AMPivotal Growth Partners Teams with Jeremiah's to Reach 100th Store Milestonefinance.yahoo.com - February 10 at 6:00 PM Get Pivotal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PVTTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details PVTTF Media Mentions By Week PVTTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PVTTF News Sentiment▼0.190.32▲Average Medical News Sentiment PVTTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PVTTF Articles This Week▼10▲PVTTF Articles Average Week Get Pivotal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PVTTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BAYRY News CAPS News CNTX News IMUC News GNMSF News GRFS News HYPMY News IMVIQ News ISCO News LVTX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PVTTF) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pivotal Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
